Latest Regulatory Progress News

Noxopharm has taken a key regulatory step by requesting a pre-IND meeting with the US FDA for its autoimmune drug candidate SOF-SKN, aiming to smooth the path for clinical development and boost its commercial appeal.

Lakes Blue Energy is positioning its Wombat Gas Project as a key contributor to Victoria's energy security and emerging AI infrastructure, with a conceptual study projecting a post-tax NPV10 of A$605 million and first gas in early 2029.

Algorae Pharmaceuticals has been appointed as a supplier under a NSW Health public hospital supply contract, marking a strategic milestone despite uncertain immediate revenue impact.

OncoSil Medical secures a spot in the PALACROS consortium, advancing its OncoSil™ device through a cost-efficient Phase II trial targeting unresectable locally advanced pancreatic cancer.

Kinetiko Energy has approved a Field Development Plan marking its shift from exploration to production at the Brakfontein gas project in South Africa, aiming to fast-track gas output and secure strategic funding.

Imugene Limited reports a complete response in the first patient treated with azer-cel combined with BTK inhibitors in its Phase 1b trial, highlighting potential for resistant follicular lymphoma.

Brazilian Critical Minerals releases a robust Bankable Feasibility Study for its Ema Rare Earth Project, highlighting a US$1.47 billion post-tax NPV and a swift 0.5-year payback period, underpinned by low capital and operating costs.

Audalia Resources (ASX: ACP) is seeking to raise $450,000 through a placement of 15 million shares at 3 cents each, aiming to fund the Medcalf project’s progression and shore up working capital.

Australian Rare Earths (ASX: AR3) has announced a maiden Ore Reserve of 26 million tonnes at 920 ppm TREO for its Koppamurra Rare Earths Project, underpinned by a robust Pre-Feasibility Study delivering an A$858 million post-tax NPV and a rapid payback of less than one year.

The a2 Milk Company has announced a $300 million fully franked special dividend following regulatory clearance in China to rebrand infant formula products under its a2 label.

EBR Systems has wrapped up the retail tranche of its fully underwritten entitlement offer, adding A$10.9 million to a total raise of about A$43.6 million to support its wireless cardiac pacing technology.

Patriot Resources has independently confirmed the reliability of historical assay data at its Tassa Silver-Gold Project in Peru, reinforcing confidence in its 31.4Moz inferred resource and clearing regulatory hurdles ahead of a maiden drill campaign.